{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T05:21:25Z","timestamp":1738992085369,"version":"3.37.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jiac.2024.10.007","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T17:24:24Z","timestamp":1728494664000},"page":"102539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Descriptive analysis of safety and immunogenicity profiles of a 15-valent pneumococcal conjugate vaccine between subcutaneous and intramuscular administration in a phase 1 study of healthy Japanese infants (V114-028)"],"prefix":"10.1016","volume":"31","author":[{"given":"Keiko","family":"Wan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Shirakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Sawata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7271","key":"10.1016\/j.jiac.2024.10.007_bib1","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1136\/bmj.321.7271.1237","article-title":"The importance of injecting vaccines into muscle. Different patients need different needle sizes","volume":"321","author":"Zuckerman","year":"2000","journal-title":"BMJ"},{"issue":"5\u20136","key":"10.1016\/j.jiac.2024.10.007_bib2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0264-410X(99)00238-8","article-title":"Studies on a Hib-tetanus toxoid conjugate vaccine: effects of co-administered tetanus toxoid vaccine, of administration route and of combined administration with an inactivated polio vaccine","volume":"18","author":"Carlsson","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2024.10.007_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1741-7015-7-16","article-title":"Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro) and a varicella vaccine (VARIVAX) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial","volume":"7","author":"Gillet","year":"2009","journal-title":"BMC Med"},{"issue":"32","key":"10.1016\/j.jiac.2024.10.007_bib4","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1016\/j.vaccine.2012.04.026","article-title":"Current issues with the immunization program in Japan: can we fill the \u201cvaccine gap\u201d","volume":"30","author":"Saitoh","year":"2012","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.jiac.2024.10.007_bib5","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1016\/j.vaccine.2014.04.018","article-title":"Inflammatory responses following intramuscular and subcutaneous immunization with aluminum-adjuvanted or non-adjuvanted vaccines","volume":"32","author":"Kashiwagi","year":"2014","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.jiac.2024.10.007_bib8","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1016\/j.vaccine.2020.09.032","article-title":"Impact of pneumococcal conjugate vaccine on pneumonia hospitalization and mortality in children and elderly in Ecuador: time series analyses","volume":"38","author":"Jimbo","year":"2020","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.jiac.2024.10.007_bib9","doi-asserted-by":"crossref","first-page":"e1062","DOI":"10.1093\/cid\/ciac475","article-title":"Distribution of serotypes causing invasive pneumococcal disease in children from high-income countries and the impact of pediatric pneumococcal vaccination","volume":"76","author":"Grant","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jiac.2024.10.007_bib10","article-title":"Burden of illness associated with pneumococcal infections in Japan - a targeted literature review","volume":"10","author":"Igarashi","year":"2022","journal-title":"J Mark Access Health Pol"},{"key":"10.1016\/j.jiac.2024.10.007_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17600-6","article-title":"Changes in serotype prevalence of Streptococcus pneumoniae in Southampton, UK between 2006 and 2018","volume":"12","author":"Cleary","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jiac.2024.10.007_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75691-5","article-title":"Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency","volume":"10","author":"Lochen","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jiac.2024.10.007_bib15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.vaccine.2022.10.072","article-title":"A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION)","volume":"41","author":"Bili","year":"2023","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jiac.2024.10.007_bib16","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.vaccine.2022.12.054","article-title":"A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED)","volume":"41","author":"Lupinacci","year":"2023","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.jiac.2024.10.007_bib17","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.15585\/mmwr.mm7137a3","article-title":"Use of 15-valent pneumococcal conjugate vaccine among U.S. Children: updated recommendations of the advisory committee on immunization practices - United States, 2022","volume":"71","author":"Kobayashi","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"year":"2023","series-title":"VAXNEUVANCE aqueous suspension syringes","key":"10.1016\/j.jiac.2024.10.007_bib18"},{"issue":"15\u201316","key":"10.1016\/j.jiac.2024.10.007_bib19","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0264-410X(98)00410-1","article-title":"Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents","volume":"17","author":"Mark","year":"1999","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jiac.2024.10.007_bib20","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2180973","article-title":"Safety and immunogenicity of a 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: a Phase I study (V114-028)","volume":"19","author":"Ishihara","year":"2023","journal-title":"Hum Vaccines Immunother"},{"issue":"1","key":"10.1016\/j.jiac.2024.10.007_bib21","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-060428","article-title":"Safety and tolerability of V114 pneumococcal vaccine in infants: a phase 3 study","volume":"152","author":"Banniettis","year":"2023","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.jiac.2024.10.007_bib22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jiac.2019.11.012","article-title":"Immunogenicity and safety of a DTaP-IPV\/Hib pentavalent vaccine given as primary and booster vaccinations in healthy infants and toddlers in Japan","volume":"26","author":"Nakayama","year":"2020","journal-title":"J Infect Chemother"},{"issue":"4","key":"10.1016\/j.jiac.2024.10.007_bib23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/21645515.2018.1549452","article-title":"Immunogenicity and safety of intramuscular versus subcutaneous administration of a combined measles, mumps, rubella, and varicella vaccine to children 12 to 18 months of age","volume":"15","author":"Haas","year":"2019","journal-title":"Hum Vaccines Immunother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24002800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24002800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:47:33Z","timestamp":1738928853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24002800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1341321X24002800"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.10.007","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Descriptive analysis of safety and immunogenicity profiles of a 15-valent pneumococcal conjugate vaccine between subcutaneous and intramuscular administration in a phase 1 study of healthy Japanese infants (V114-028)","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102539"}}